Aptiv
APTV
743 hedge funds and large institutions have $36.8B invested in Aptiv in 2021 Q3 according to their latest regulatory filings, with 88 funds opening new positions, 303 increasing their positions, 234 reducing their positions, and 52 closing their positions.
69% more first-time investments, than exits
New positions opened: 88 | Existing positions closed: 52
29% more repeat investments, than reductions
Existing positions increased: 303 | Existing positions reduced: 234
4% more funds holding
Funds holding: 715 → 743 (+28)
0.47% more ownership
Funds ownership: 91.34% → 91.82% (+0.47%)
5% less capital invested
Capital invested by funds: $38.8B → $36.8B (-$1.97B)
17% less call options, than puts
Call options by funds: $142M | Put options by funds: $170M
23% less funds holding in top 10
Funds holding in top 10: 13 → 10 (-3)
Top Buyers
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$948M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$72.2M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$60M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$56.6M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$47.7M |
APTV Hedge Fund Activity: Q3 2021 in Review
743 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Aptiv (APTV) for Q3 2021, worth a combined $36.8B — down 5.1% from $38.8B a quarter earlier.
Buyers outnumbered sellers: 88 funds opened new APTV positions and 52 closed out — a net gain of 36 holders — while 303 added to existing stakes and 234 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $219M. The largest seller was T. Rowe Price Associates, cutting an estimated $948M.
- 743 institutional investors held Aptiv (APTV) as of Q3 2021, up from 715 in Q2 2021.
- Funds reported $36.8B of Aptiv stock for Q3 2021, down 5.1% quarter-over-quarter.
- 88 funds opened new Aptiv positions in Q3 2021 and 52 closed out, a net change of +36 holders.
- The largest Aptiv buyer in Q3 2021 was Capital Research Global Investors, an estimated $219M added.
- The largest Aptiv seller in Q3 2021 was T. Rowe Price Associates, an estimated $948M sold.
Based on aggregated 13F filings for Q3 2021.